TY - JOUR
T1 - High circulating adiponectin levels predict decreased muscle strength among older adults aged 70 years and over
T2 - A prospective cohort study
AU - Huang, C.
AU - Tomata, Y.
AU - Kakizaki, M.
AU - Sugawara, Y.
AU - Hozawa, A.
AU - Momma, H.
AU - Tsuji, I.
AU - Nagatomi, R.
N1 - Publisher Copyright:
© 2015 Elsevier B.V.
PY - 2015/6/1
Y1 - 2015/6/1
N2 - Background and aims: Population-based researches indicate that circulating adiponectin is inversely associated with muscle strength. However, interpretation of the findings has been limited by the use of a cross-sectional design. This study aimed to examine the prospective relationship between baseline circulating adiponectin concentration and change in muscular function-related physical performance in older adults. Methods and results: A 1-year prospective cohort study of Japanese community-dwelling elderly was conducted between 2002 and 2003. Four hundred thirty-four older persons participated in the measurements of physical function, including leg extension power, functional reach, timed up-and-go test, and 10-m maximum walking speed, at baseline and follow-up. After adjustment for potential covariates, higher serum adiponectin concentration was found to be significantly associated with poorer physical performance at baseline (leg extension power [watt], P<0.001; functional reach [cm], P<0.001; log timed up-and-go test, P=0.007; log 10-m maximum walking speed, P<0.001). The results of the prospective analysis by analysis of covariance indicated that the elderly with higher serum adiponectin concentrations (tertiles) at baseline tended to have a decreased performance in leg extension power (means [95% confidence interval]: lowest, -105 [-125, -85.7]; middle, -117 [-135, -97.8]; highest, -140 [-160, -120], watt, P for trend=0.021) and timed up-and-go test (lowest, -0.08 [-0.28, -0.12]; middle, -0.10 [-0.29, 0.10]; highest, 0.28 [0.07, 0.48], s, P for trend=0.019), but not two other functioning. Conclusion: High circulating adiponectin concentration may be an indicator of decreased physical performance, especially muscle strength, in older adults.
AB - Background and aims: Population-based researches indicate that circulating adiponectin is inversely associated with muscle strength. However, interpretation of the findings has been limited by the use of a cross-sectional design. This study aimed to examine the prospective relationship between baseline circulating adiponectin concentration and change in muscular function-related physical performance in older adults. Methods and results: A 1-year prospective cohort study of Japanese community-dwelling elderly was conducted between 2002 and 2003. Four hundred thirty-four older persons participated in the measurements of physical function, including leg extension power, functional reach, timed up-and-go test, and 10-m maximum walking speed, at baseline and follow-up. After adjustment for potential covariates, higher serum adiponectin concentration was found to be significantly associated with poorer physical performance at baseline (leg extension power [watt], P<0.001; functional reach [cm], P<0.001; log timed up-and-go test, P=0.007; log 10-m maximum walking speed, P<0.001). The results of the prospective analysis by analysis of covariance indicated that the elderly with higher serum adiponectin concentrations (tertiles) at baseline tended to have a decreased performance in leg extension power (means [95% confidence interval]: lowest, -105 [-125, -85.7]; middle, -117 [-135, -97.8]; highest, -140 [-160, -120], watt, P for trend=0.021) and timed up-and-go test (lowest, -0.08 [-0.28, -0.12]; middle, -0.10 [-0.29, 0.10]; highest, 0.28 [0.07, 0.48], s, P for trend=0.019), but not two other functioning. Conclusion: High circulating adiponectin concentration may be an indicator of decreased physical performance, especially muscle strength, in older adults.
KW - Adipokine
KW - Aging
KW - Physical function
KW - Sarcopenia
UR - http://www.scopus.com/inward/record.url?scp=84930182579&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930182579&partnerID=8YFLogxK
U2 - 10.1016/j.numecd.2015.03.010
DO - 10.1016/j.numecd.2015.03.010
M3 - Article
C2 - 25921841
AN - SCOPUS:84930182579
SN - 0939-4753
VL - 25
SP - 594
EP - 601
JO - Nutrition, Metabolism and Cardiovascular Diseases
JF - Nutrition, Metabolism and Cardiovascular Diseases
IS - 6
ER -